Jefferies Financial Group Inc. Buys 39,333 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Jefferies Financial Group Inc. raised its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 37.7% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 143,673 shares of the company's stock after buying an additional 39,333 shares during the period. Jefferies Financial Group Inc.'s holdings in GE HealthCare Technologies were worth $11,232,000 as of its most recent SEC filing.

A number of other large investors have also recently added to or reduced their stakes in the business. Humankind Investments LLC boosted its holdings in GE HealthCare Technologies by 8.2% during the fourth quarter. Humankind Investments LLC now owns 17,876 shares of the company's stock worth $1,398,000 after buying an additional 1,350 shares in the last quarter. Graham Capital Management L.P. purchased a new position in GE HealthCare Technologies during the 4th quarter worth approximately $1,643,000. Focus Partners Wealth grew its position in GE HealthCare Technologies by 30.5% during the 4th quarter. Focus Partners Wealth now owns 699,496 shares of the company's stock worth $54,836,000 after purchasing an additional 163,438 shares in the last quarter. Ellevest Inc. grew its position in GE HealthCare Technologies by 8.3% during the 4th quarter. Ellevest Inc. now owns 3,515 shares of the company's stock worth $275,000 after purchasing an additional 270 shares in the last quarter. Finally, Ensign Peak Advisors Inc grew its position in GE HealthCare Technologies by 15.8% during the 4th quarter. Ensign Peak Advisors Inc now owns 78,790 shares of the company's stock worth $6,160,000 after purchasing an additional 10,770 shares in the last quarter. 82.06% of the stock is currently owned by institutional investors.

GE HealthCare Technologies Stock Up 0.3%

Shares of GEHC stock traded up $0.22 on Friday, hitting $73.13. The company's stock had a trading volume of 3,308,976 shares, compared to its average volume of 3,418,814. The stock has a market capitalization of $33.49 billion, a price-to-earnings ratio of 16.89, a P/E/G ratio of 3.19 and a beta of 1.21. GE HealthCare Technologies Inc. has a fifty-two week low of $57.65 and a fifty-two week high of $94.80. The firm's fifty day moving average price is $71.27 and its 200-day moving average price is $80.16. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 0.83.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last posted its earnings results on Wednesday, April 30th. The company reported $1.01 earnings per share for the quarter, beating the consensus estimate of $0.91 by $0.10. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. The company had revenue of $4.78 billion for the quarter, compared to analyst estimates of $4.66 billion. During the same period last year, the company earned $0.90 earnings per share. The business's revenue was up 2.7% compared to the same quarter last year. Research analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies declared that its Board of Directors has authorized a share buyback plan on Wednesday, April 30th that authorizes the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization authorizes the company to purchase up to 3.1% of its shares through open market purchases. Shares repurchase plans are generally a sign that the company's board believes its shares are undervalued.

GE HealthCare Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Thursday, May 15th. Investors of record on Friday, April 25th were paid a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.19%. The ex-dividend date was Friday, April 25th. GE HealthCare Technologies's payout ratio is 2.95%.

Wall Street Analyst Weigh In

Several equities analysts have weighed in on GEHC shares. UBS Group upgraded shares of GE HealthCare Technologies from a "sell" rating to a "neutral" rating and lowered their price objective for the stock from $74.00 to $73.00 in a research report on Monday, May 5th. Morgan Stanley lowered their price objective on shares of GE HealthCare Technologies from $86.00 to $78.00 and set an "equal weight" rating on the stock in a research report on Tuesday, May 6th. BTIG Research set a $95.00 price objective on shares of GE HealthCare Technologies and gave the stock a "buy" rating in a research report on Monday, April 14th. Citigroup lowered their price objective on shares of GE HealthCare Technologies from $105.00 to $86.00 and set a "buy" rating on the stock in a research report on Wednesday, April 30th. Finally, The Goldman Sachs Group decreased their target price on shares of GE HealthCare Technologies from $94.00 to $82.00 and set a "buy" rating for the company in a research note on Thursday, May 1st. Three investment analysts have rated the stock with a hold rating, eight have given a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average target price of $88.27.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.